344 related articles for article (PubMed ID: 8620488)
21. KAI1 protein is down-regulated during the progression of human breast cancer.
Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M
Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724
[TBL] [Abstract][Full Text] [Related]
22. Significance of integrin alpha5 gene expression as a prognostic factor in node-negative non-small cell lung cancer.
Adachi M; Taki T; Higashiyama M; Kohno N; Inufusa H; Miyake M
Clin Cancer Res; 2000 Jan; 6(1):96-101. PubMed ID: 10656437
[TBL] [Abstract][Full Text] [Related]
23. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
Bouras T; Frauman AG
J Pathol; 1999 Aug; 188(4):382-8. PubMed ID: 10440748
[TBL] [Abstract][Full Text] [Related]
24. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82.
Hashida H; Takabayashi A; Tokuhara T; Taki T; Kondo K; Kohno N; Yamaoka Y; Miyake M
Int J Cancer; 2002 Feb; 97(4):518-25. PubMed ID: 11802216
[TBL] [Abstract][Full Text] [Related]
25. [KAI1/CD82 and ME491/CD63 expression in non-small-cell carcinoma of the lung and prognosis].
Adachi M; Taki T; Ieki Y; Ko S; Higashiyama S; Kodama K; Doi S; Miyake M
Nihon Kyobu Geka Gakkai Zasshi; 1997 Mar; 45(3):398-401. PubMed ID: 9235357
[No Abstract] [Full Text] [Related]
26. Loss of KAI1 expression in gastric cancer.
Tsutsumi S; Shimura T; Morinaga N; Mochiki E; Asao T; Kuwano H
Hepatogastroenterology; 2005; 52(61):281-4. PubMed ID: 15783050
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
28. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
[TBL] [Abstract][Full Text] [Related]
29. KAI1 gene expression in hepatocellular carcinoma and its relationship with intrahepatic metastases.
Sun HC; Tang ZY; Zhou G; Li XM
J Exp Clin Cancer Res; 1998 Sep; 17(3):307-11. PubMed ID: 9894767
[TBL] [Abstract][Full Text] [Related]
30. Frequent low level expression in Ewing sarcoma family tumors and widespread absence of the metastasis suppressor KAI1/CD82 in neuroblastoma.
Aryee DN; Ambros I; Ambros PF; Muehlbacher K; Luegmayr A; Yoshie O; Kovar H
Pediatr Res; 2002 Aug; 52(2):279-85. PubMed ID: 12149507
[TBL] [Abstract][Full Text] [Related]
31. Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression.
Lee JH; Seo YW; Park SR; Kim YJ; Kim KK
Cancer Res; 2003 Nov; 63(21):7247-55. PubMed ID: 14612520
[TBL] [Abstract][Full Text] [Related]
32. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines.
White A; Lamb PW; Barrett JC
Oncogene; 1998 Jun; 16(24):3143-9. PubMed ID: 9671393
[TBL] [Abstract][Full Text] [Related]
33. Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells.
Wu Q; Ji Y; Zhang MQ; Chen YQ; Chen F; Shi DL; Zheng ZH; Huang YJ; Su WJ
Cell Tissue Res; 2003 Nov; 314(2):237-49. PubMed ID: 12955496
[TBL] [Abstract][Full Text] [Related]
34. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer.
Sho M; Adachi M; Taki T; Hashida H; Konishi T; Huang CL; Ikeda N; Nakajima Y; Kanehiro H; Hisanaga M; Nakano H; Miyake M
Int J Cancer; 1998 Oct; 79(5):509-16. PubMed ID: 9761121
[TBL] [Abstract][Full Text] [Related]
35. Expression of the KAI1 metastasis suppressor gene in non-metastatic versus metastatic human colorectal cancer.
Yang JL; Jackson P; Yu Y; Russell PJ; Markovic B; Crowe PJ
Anticancer Res; 2002; 22(6A):3337-42. PubMed ID: 12530084
[TBL] [Abstract][Full Text] [Related]
36. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
Chang YS; Wang L; Liu D; Mao L; Hong WK; Khuri FR; Lee HY
Clin Cancer Res; 2002 Dec; 8(12):3669-75. PubMed ID: 12473575
[TBL] [Abstract][Full Text] [Related]
37. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
38. Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer.
Ueda T; Ichikawa T; Tamaru J; Mikata A; Akakura K; Akimoto S; Imai T; Yoshie O; Shiraishi T; Yatani R; Ito H; Shimazaki J
Am J Pathol; 1996 Nov; 149(5):1435-40. PubMed ID: 8909232
[TBL] [Abstract][Full Text] [Related]
39. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
